Subang Jaya Medical Centre (SJMC) Wins Frost & Sullivan Asia Pacific Best Practices Award for “2022 Malaysia Best Hospital Company of The Year” for a Second Time

    36
    Bryan Lin, Chief Executive Officer of SJMC

    Subang Jaya, Malaysia, 18 July 2022 – For the second year running, Subang Jaya Medical Centre (SJMC) was named winner of the prestigious Frost & Sullivan Asia Pacific Best Practices Award for Malaysia Best Hospital Company of The Year

    Bryan Lin, Chief Executive Officer of SJMC said, “We are truly honoured for this coveted award with a consecutive win. As a household name in Malaysia’s private healthcare, we have always been committed to clinical excellence, medical advancement, and patient-centric care. This recognition would not have been possible without our dedicated team of medical professionals and staff who put our patients first.”

    Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies and the resulting leadership in terms of customer value and market penetration.

    A hospital of many firsts

    Bryan added, “As a trusted name since 1985, we are proud to be a hospital of many firsts. In the private healthcare sector, SJMC conducted the first open heart surgery, stem cell transplant, bone marrow transplant, live-related paediatric liver transplant, and brain neurosurgery. 

    Recently, we performed the first daycare total knee replacement surgery and achieved a milestone of 800 bone marrow transplants performed since 1999. We’ve also stamped another first in offering tomography services for efficient and high-precision cancer treatment as well as digital PET/CT services. This means better precision, reduced radiation, and shorter time for our patients.”

    SJMC’s vision involves developing partnerships to provide the best private healthcare to help patients lead better lives. The company connects deep-seated domain and operational knowledge with advanced services to deliver care during the COVID-19 pandemic. The hospital adapts real-time reverse transcription polymerase chain reaction tests to reduce the waiting time for patient admission. 

    A hospital with continuous innovation 

    With Home Connect, home care services are available to patients who cannot commute to the hospital, either because of the difficulty in physically commuting or as a precaution against COVID-19. The service allows nurses or physiotherapists to visit patients in their homes, especially after surgery. In addition, the service includes home delivery of long-term medication. The hospital’s Home Connect service is convenient and creates a shift in modern healthcare because it complies with clinical care standards and provides patients and their families with peace of mind.

    According to Siddharth Shah, Research Manager for Frost & Sullivan, “SJMC seamlessly assimilates into the post-pandemic private medical care scene and emerges as a leader in providing contactless home care as a permanent mode of care delivery, an extensive offering unique to the market.”

    SJMC’s selected rehabilitation services, such as physiotherapy and palliative care, are available for home care visits. Its teleconnect center provides 24-hour convenience of obtaining medical advisory services over the phone or through WhatsApp to improve customer service. 

    Upholding High Standards of Excellence 

    It conducts nursing training initiatives to prevent errors in medication and intravenous care, uphold therapy and medication safety standards, and support the continuous development of its healthcare staff. SJMC has a leadership legacy; therefore, its compelling value proposition underpins its sustained success. 

    The company’s brand equity, unwavering focus on leadership, best practices implementation, customer-centric focus, and continual and proactive innovation contribute to its sustained success and leading market position.

    “SJMC meets with patients to assess their specific needs and develop tailored solutions with roadmaps for seamless execution. This foundational approach establishes ongoing trust with customers for long-lasting relationships extending throughout the service lifecycle,” explained Azza Fazar, Best Practices Research Analyst for Frost & Sullivan. 

    “The hospital remains a trusted partner, earning a reputation for offering the overall best care in the hospital space,” Azza adds. 

    Frost & Sullivan Best Practices Awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

    SJMC is accredited by Joint Commission International (JCI) and the Malaysian Society for Quality in Health (MSQH), and its medical laboratories are certified by the International Organization for Standardization (ISO). 

    As part of the Ramsay Sime Darby Health Care Group, SJMC ensures its medical practitioners and administrative staff provide top-notch private healthcare. The multi-disciplinary private healthcare service provider has a capacity of 444 beds, a long history, and remarkable milestones, all contributing to its leadership position in Malaysia’s medical industry.